KalVista Pharmaceuticals (KALV) Q2 2023 Earnings

7JulConfirmed
Sep 22
Dec 22
Q4 2022
Q2 2023
-1.06
-0.96
-0.85
-0.75

Details

Expected EPS
-0.94
Actual EPS
-0.77
Surprise EPS
0.17
Surprise Percent
+18.09%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.77 per share for Q2 2023.

0 Comments

Share your thoughts